Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abcam plc

Abcam plc (ABCM) Stock Overview

Explore Abcam plc’s financial performance, market position, analyst ratings, and future outlook.

ABCM●NASDAQ
HealthcareBiotechnology
$23.99
$0.010(0.04%)
U.S. Market is Open · 15:09

Abcam plc (ABCM)

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-479.42
EPS (TTM)$0.01
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$50.38

ABCM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Abcam plc (NASDAQ: ABCM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Abcam plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABCM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $50.38 for the NASDAQ listing.

Key metrics behind Abcam plc's NASDAQ-traded stock include a P/E ratio of -479.42 and a market capitalization of 5.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABCM on the NASDAQ.

Price Performance (NASDAQ: ABCM)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.04%
3-Month Change
5.45%
6-Month Change
-0.04%
Year-to-Date (YTD) Change
N/A
1-Year Change
41.12%
3-Year Change
17.20%
5-Year Change
66.29%
All-Time (Max) Change
376.02%

Contact Information

https://www.abcam.com
44 12 2369 6000
Discovery Drive, Cambridge, NaN, CB2 0AX

Company Facts

17,600 Employees
IPO DateOct 22, 2020
CountryGB

Frequently Asked Questions